Table TDI-8. Primary use of stimulants of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (ii) All clients by country and type of stimulant (%)

Country		Amphetamines	%	Ecstasy	%	Other stimulants	%	Total
Belgium		835	88.5	83	8.8	25	2.7	943
Bulgaria		20	87.0	3	13.0	0	0.0	23
Czech Republic		4896	99.5	8	0.2	17	0.3	4921
Denmark		395	95.6	18	4.4	0	0.0	413
Germany	(1)	0	:	0	:	0	:	4725
Estonia		15	100.0	0	0.0	0	0.0	15
Ireland		31	30.1	70	68.0	2	1.9	103
Greece		2	50.0	2	50.0	0	0.0	4
Spain	(2)	424	67.1	164	25.9	44	7.0	632
France		71	35.0	122	60.1	10	4.9	203
Italy		44	28.9	86	56.6	22	14.5	152
Cyprus		3	42.9	3	42.9	1	14.3	7
Latvia		:	:	:	:	:	:	:
Lithuania		:	:	:	:	:	:	:
Luxembourg		1	50.0	1	50.0	0	0.0	2
Hungary		433	89.5	43	8.9	8	1.7	484
Malta		1	8.3	11	91.7	0	0.0	12
Netherlands		636	88.1	48	6.6	38	5.3	722
Austria		73	73.7	16	16.2	10	10.1	99
Poland	(2)	514	0.0	19	0.0	9	0.0	542
Portugal		:	:	:	:	:	:	:
Romania		3	42.9	4	57.1	0	0.0	7
Slovenia		4	80.0	1	20.0	0	0.0	5
Slovakia		531	99.3	2	0.4	2	0.4	535
Finland		328	96.8	2	0.6	9	2.7	339
Sweden		1720	98.9	14	0.8	6	0.3	1740
United Kingdom		4315	87.4	450	9.1	173	3.5	4938
Croatia		137	64.0	54	25.2	23	10.7	214
Turkey		0	0.0	31	93.9	2	6.1	33
Norway		:	:	:	:	:	:	:
Total		15432	90.3%	1255	7.3%	401	2.3%	17088

Notes:

 : Indicates no data available 

 All types of treatment centres as defined by TDI Protocol 2.0 are included. 

 Percentages are of clients in treatment for stimulants as primary drug 

 (1) Only the aggregated data for Stimulants Total is available. 

 (2) Last data available refer to 2008.  

 See also '‘General notes for interpreting data'’ on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2010 — Standard table 3. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)